A genetic variant in CDKN2A/B gene is associated with the increased risk of breast cancer.

Soodabeh ShahidSalesMehraneh MehramizFaezeh GhasemiAmir AledavoodMehri ShamsiSeyed Mahdi HassanianMajid Ghayour-MobarhanSoodabeh Shahidsales

Published in: Journal of clinical laboratory analysis (2017)

We demonstrated that patients carrying the TT genotype for CDKN2A/B rs10811661 polymorphism had the increased risk of breast cancer susceptibility. However, further investigations are warranted in a larger and prospective setting to explore the value of this marker as a risk stratification marker in breast cancer.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
genome wide
copy number
chronic kidney disease
peritoneal dialysis
prognostic factors
gene expression
dna methylation
young adults